menu search

Nvidia and amgen back ai drug developer generate:biomedicines' $273m financing

Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical a...

September 14, 2023, 11:29 am

Sensei biotherapeutics to present new preclinical data supporting mechanism of action, pharmacokinetic profile and safety characteristics for sns-101, a conditionally active vista-blocking antibody, a

BOSTON, Sept. 13, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the disco...

September 13, 2023, 11:30 am

Ideaya's triple threat: melanoma, money, and momentum

IDEAYA Biosciences specializes in precision oncology, has FDA clearance for a Phase 1/2 trial, and partnerships with Amgen and GSK. Financially stable...

September 13, 2023, 6:19 am

Molecular partners presents new data on its radio darpin therapy (rdt) platform at the eanm 2023 annual meeting

New preclinical RDT data show that DARPins can be engineered to increase tumor uptake as well as reduci...

September 13, 2023, 5:00 am

Journal of cellular and molecular medicine publishes preclinical data of panavance’s gp-2250 to treat pancreatic cancer

Results showed antineoplastic activity in pancreatic tumor cell lines Metabolic and transcriptional findings demonstrate a molecular basis to reduce t...

September 12, 2023, 11:07 am

Pfizer says updated covid shot generated strong reaction vs new variant in mice

Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the hi...

September 6, 2023, 2:10 pm

Revvity (rvty) launches three new preclinical research systems

Revvity (RVTY) launches new preclinical imaging technologies for breakthrough discoveries. Learn how th...

September 6, 2023, 11:18 am

Why is neubase therapeutics (nbse) stock up 19% today?

NeuBase Therapeutics (NASDAQ: NBSE ) stock is taking off on Wednesday despite a lack of news from the preclin...

September 6, 2023, 8:04 am

Nuvectis: early stage company that's low on cash

Nuvectis is developing precision medicines for cancer patients, with lead asset NXP800 targeting ARID1a-mutated ovarian cancer. ...

September 6, 2023, 8:03 am

Pepgen announces presentations at the 2023 myotonic dystrophy foundation annual conference, ottawa neuromuscular disease meeting, and h.c. wainwright 25th annual global investment conference

BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonu...

September 1, 2023, 8:00 am

Ocean biomedical: some new targets, no clinical data. not for me

Ocean Biomedical is a biotech company focused on generating lead candidates for clinical development. They have programs in various therapeutic areas,...

August 28, 2023, 7:40 pm

Gain therapeutics presents new preclinical data demonstrating a reduction of plasma neurodegeneration biomarker nfl after administration of its drug candidate gt-02287 in gba1 parkinson’s disease mode

Treatment with GT-02287 also restored glucocerebrosidase (GCase) enzymatic function, reduced aggregated α-synuclein, neuroinflammation and neuronal d...

August 28, 2023, 11:00 am

Biovie showcases promising data for ne3107 at international parkinson's disease event

BioVie Inc (NASDAQ:BIVI) said new preclinical data characterizing its lead drug candidate NE3107's mech...

August 28, 2023, 9:06 am

Lyell immunopharma: once huge ipo now waiting for clinical data

Lyell is a developer of personalized T-cell therapies for solid tumors, with two programs targeting various types of solid tumors. Their pipeline incl...

August 26, 2023, 9:29 am

Centessa pharmaceuticals to present preclinical data for novel orexin receptor 2 (ox2r) agonist at world sleep congress

Oral presentation to include preclinical profile for ORX750, Centessa's first orexin agonist developmen...

August 23, 2023, 5:08 pm

Novavax's updated covid vaccine shows response against 'eris' variant

Novavax Inc said on Tuesday its updated protein-based COVID-19 vaccine generated neutralizing antibody responses to the "Eris" subvariant in ...

August 22, 2023, 7:17 am

Tonix pharmaceuticals announces results of pre-ind meeting with fda for tnx-801 as a potential vaccine to prevent mpox and smallpox

Phase 1/2 Clinical Trial of TNX-801 for the Prevention of Mpox and Smallpox to Commence Following Submission of an IND TNX-801 is Based on a Proprieta...

August 21, 2023, 11:00 am

Enliven therapeutics: preclinical company with interesting value proposition

Enliven Therapeutics, Inc. is a recently merged biopharma company focused on developing oncology candidates for leukemia and lymphoma. The company has...

August 18, 2023, 12:57 pm

Johnson & johnson (jnj) presents at ubs medtech, tools and genomics summit conference (transcript)

Johnson & Johnson (NYSE:JNJ ) UBS MedTech, Tools and Genomics Summit Conference Call August 15, 2023 2:00 PM ET Company Participants Celine Martin - G...

August 15, 2023, 8:01 pm

Cidara therapeutics: leveraging antifungals to move into cancer therapy

Cidara Therapeutics is a biotech company with an approved antifungal drug, Rezzayo, but its sales are not enough to offset expenses. The company's pip...

August 10, 2023, 5:50 pm


Search within

Pages Search Results: